Sign in

You're signed outSign in or to get full access.

Natasha Fernandes

Chief Financial Officer and Executive Vice President at IMAXIMAX
Executive

About Natasha Fernandes

Natasha Fernandes (age 44) is Chief Financial Officer and Executive Vice President of IMAX, a 17+ year company veteran who rose through finance leadership roles (Deputy CFO, Corporate Treasurer) before becoming CFO in May 2022; she holds a BBA from Wilfrid Laurier University and is a member of CPA Canada . Under her tenure as a senior finance leader, IMAX delivered 2024 TSR of 70.4%, with three-year average Adjusted EBITDA growth of 24.0% and TSR positioned around the 80th percentile of the Russell 2000; 2022 PSU awards paid out at 154.4% of target on these results . 2024 performance translated into NEO bonus outcomes of 97.3%–108.5% of target (Fernandes at 108.5%), evidencing pay-for-performance alignment .

Past Roles

OrganizationRoleYearsStrategic impact
IMAX CorporationChief Financial Officer & EVPMay 2022–presentLeads global finance; stewarded capital allocation and investor relations; executed cost reductions and tax optimization; supported liquidity and risk management .
IMAX CorporationDeputy CFO & SVP2021–2022Oversaw accounting, treasury, forecasting, budgeting, long-range planning worldwide .
IMAX CorporationCorporate Treasurer; VP Finance & Corporate Treasurer2018–2021Led $200M convertible debt offering (2021) and new credit agreement (2022) .
IMAX CorporationProgressive finance roles (VP Finance & Assistant Controller; Senior Director; Director, Financial Reporting)2007–2018Built core finance capabilities across reporting and controls .
DeloitteAudit ManagerPre-2007External audit experience in manufacturing and services .

External Roles

OrganizationRoleYearsStrategic impact
IMAX Theatres International Limited (wholly-owned subsidiary)Directorn/aSubsidiary board role aligned with IMAX global theatres operations .
Chartered Professional Accountants CanadaMembern/aProfessional accreditation supporting CFO duties .

Fixed Compensation

Component20232024Notes
Base Salary (currency)CAD 500,000 CAD 550,000 (10% increase effective Apr 1, 2024) Annual review per employment agreement .
Target Bonus (% of salary)55% 60% Market adjustments in 2023 and 2024 .
Actual Annual BonusUSD 300,000 (2023) CAD 350,000 (108.5% of target) 2024 outcome reflects 50% quantitative/50% qualitative structure .
Target Annual Equity (minimum grant-date fair value)USD 600,000 USD 600,000 Mix consistent with other senior execs .
2024 Stock Awards (grant-date fair value)USD 799,972 (23,710 RSUs; 21,929 PSUs; grant 7-Mar-2024) RSUs time-based; PSUs performance-based .

Performance Compensation

2024 Annual Cash Bonus Plan – Quantitative Scorecard (applies company-wide)

MetricWeightThresholdTargetMaximumActualPayout for metric
Total Revenue ($m)25%328.1 386.0 463.2 352.2 71%
Total Adjusted EBITDA ($m)19%124.5 146.5 175.8 138.9 83%
Free Cash Flow before Growth CAPEX ($m)13%59.5 70.0 84.0 54.0 0%
Installations (count)19%119 140 168 146 121%
Signings (count)19%111 130 156 130 100%
Streaming Technology Bookings ($m)6%12.8 15.0 18.0 3.2 0%
Quantitative factor result74.7% of target
  • For Fernandes, the bonus split is 50% quantitative and 50% qualitative; her qualitative assessment was 142% of target (leadership on IR/multiples re-rating, tax strategy execution, cost optimization, capital allocation and risk management) . This yielded an overall payout of 108.5% of target for 2024 (CAD 350,000) .

Long-Term Incentives (PSUs and RSUs)

Grant yearInstrumentVesting/PerformanceMetric weighting and goalsMax vesting
2024PSUs3-year (to 12/31/2026) 60% Avg Annual Adjusted EBITDA Growth: 5%/10%/12.5% threshold/target and ≥20% max; 40% Relative TSR vs custom peer group: 25th/50th/≥90th percentile 175% (EBITDA) / 150% (TSR)
2024RSUsTime-based33%/33%/34% on 7-Mar-2025/2026/2027 (7,903/7,903/7,904 units)
2022PSUs (payout)Completed 12/31/2024EBITDA growth actual 24.0% → 175% vesting; Relative TSR 79th percentile → 123.5% vesting; blended payout 154.4% 175%

Equity Ownership & Alignment

ItemDetail
Beneficial ownership (as of 4/14/2025)31,257 common shares; plus 2,652 options exercisable within 60 days; total 33,909; <1% of outstanding .
Options outstanding2,652 options exercisable at $22.49, expiring March 7, 2026 .
Recent option exerciseExercised 2,957 options on Dec 9, 2024 due to March 2025 expiry and impending Q4 blackout per policy explanation .
RSUs unvested (by cohort)7,422 RSUs (vest 3/7/2025); 13,852 RSUs (6,925 vest 3/7/2025; 6,927 vest 3/7/2026); 23,710 RSUs (7,903 vest 3/7/2025; 7,903 vest 3/7/2026; 7,904 vest 3/7/2027) .
PSUs outstanding and expected vesting windows7,422 PSUs (vest Q1’25 subject to performance); 6,715 & 12,466 PSUs (vest Q1’26 subject to performance); 7,703 & 14,226 PSUs (vest Q1’27 subject to performance) .
Ownership guidelines (status)Required to hold 100% of salary (pro-rata 75% in 2025); current ownership equals 192% of salary; in compliance .
Hedging/PledgingProhibited under Insider Trading Policy (hedging, margin, pledging) .
ClawbackDodd-Frank-compliant clawback policy covering cash and equity incentive comp tied to financial metrics (including TSR) .

Implication: The 2025–2027 RSU/PSU vesting calendar implies periodic share deliveries that could create modest, time-based selling liquidity, while options form a de minimis component (2,652 remaining) with 2026 expiry .

Employment Terms

TopicKey terms
Employment agreementEffective May 1, 2022; open term; initial base CAD 460,161.37; increased to CAD 500,000 (Apr 1, 2023) and CAD 550,000 (Apr 1, 2024); target bonus: 50% initially, 55% for 2023 performance, 60% thereafter; annual equity award minimum USD 600,000 .
Termination without cause (no CIC)Pro‑rata target bonus for year; severance = one month of salary per year of service up to 24 months, plus target bonus and auto allowance; healthcare continued during salary continuation; equity continues to vest during salary continuation; vested options exercisable until earlier of six months post salary continuation or normal expiry .
Change-in-control (CIC)If terminated without cause in connection with a CIC: same severance benefits; options and RSUs accelerate; PSUs vest based on higher of performance up to the day before CIC or actual at end of period .
Potential payout estimates (as of 12/31/2024; IMAX $25.60/sh)Death/Disability: equity value $1,312,952; Termination without cause: cash $1,160,247; equity vesting value $2,790,861; total $3,951,108; Involuntary termination within two years of CIC: cash $1,160,247; equity value $2,993,186; total $4,153,433 .

Performance & Track Record

  • 2024 compensation outcome reflects both quantitative performance (74.7% factor) and Fernandes’ qualitative leadership (142% factor), culminating in 108.5% of target bonus (CAD 350,000) .
  • As Deputy CFO/Treasurer, led $200M convert (2021) and new credit agreement (2022), supporting balance sheet flexibility; as CFO, drove cost reduction and tax strategies, contributing to liquidity and efficiency amid China softness and strike-impacted slates .
  • IMAX’s three-year value creation translated to 2022 PSU vesting at 154.4% (EBITDA growth 24.0%; TSR 79th percentile vs Russell 2000 constituents), reinforcing alignment of long-term incentives with outcomes .

Compensation Structure Diagnostics

  • Mix and at-risk pay: For non-CEO NEOs, target pay is majority variable/equity; Fernandes’ 2024 equity target USD 600k with 50/50 PSU/RSU design (PSUs earned 0–165% of target) .
  • Annual plan metrics emphasize top-line (Revenue), profitability (Adjusted EBITDA), cash generation (FCF ex Growth CAPEX), and growth drivers (Installations, Signings, Streaming bookings), aligning to strategic levers; 2024 targets displayed rigor (two metrics zeroed, two above target) .
  • Governance guardrails: Share ownership guideline (compliant), anti-hedging/pledging, and clawback policy reduce misalignment/financial restatement risk .

Say‑on‑Pay, Peer Group, and Shareholder Feedback

  • 2024 Say‑on‑Pay support improved to 72.5% (up >25 pts vs 2023) following outreach to holders of ~67% of shares; feedback supportive of structure and enhanced disclosure .
  • Peer group for compensation benchmarking spans media/tech/entertainment names (e.g., Dolby, Cinemark, Lions Gate, Ambarella, Harmonic; specific list in filing); no rigid percentile targeting to preserve judgment given IMAX’s unique model .

Risk Indicators & Red Flags

  • Hedging/pledging: Prohibited (reduces misalignment/forced selling risk) .
  • Clawback: In place and compliant (reduces restatement-related windfalls) .
  • Related-party transactions: None disclosed for Fernandes; none material reported for executives in 2024 .
  • Award modifications/repricings: None disclosed; option exercises in 2024 were driven by upcoming expiration and trading blackout timing .

Equity Vesting & Insider Selling Pressure (Next 24–30 Months)

Date/WindowInstrumentSharesNotes
Mar 7, 2025RSU vests7,422 + 6,925 + 7,903 = 22,2503 RSU tranches vest same day .
Q1 2025PSU settlement7,422 (subject to performance)2022–2024 PSU cycle .
Mar 7, 2026RSU vests6,927 + 7,903 = 14,8302023/2024 RSUs .
Q1 2026PSU settlement6,715 + 12,466 = 19,181 (subject to performance)2023–2025 PSU cycle .
Mar 7, 2027RSU vests7,904Final 2024 RSU tranche .
Q1 2027PSU settlement7,703 + 14,226 = 21,929 (subject to performance)2024–2026 PSU cycle .
Mar 7, 2026Option expiry2,652 options @ $22.49Residual legacy options expirying in 2026 .

Note: Actual delivered PSU shares will depend on Adjusted EBITDA growth and relative TSR performance for each tranche .

Investment Implications

  • Alignment and retention: Fernandes is meaningfully aligned via ownership (192% of salary vs 75% pro‑rata guideline) with ongoing share delivery through 2027, and anti‑hedging/pledging plus a robust clawback policy mitigate misalignment risks . Severance is tenure-based (up to 24 months) with equity continuation/acceleration features that are competitive but not excessive; estimated CIC cash+equity exposure is ~$4.15M as of 12/31/24 .
  • Incentive design and performance sensitivity: The 50/50 PSU/RSU LTI mix with high hurdles (double‑digit EBITDA growth and high TSR percentile for max) keeps upside tied to durable fundamentals and market-relative returns; 2024 annual metrics evidenced target rigor (quantitative factor 74.7%) and tempered cash payouts, while recognizing individual execution (142% qualitative for CFO) .
  • Liquidity/overhang: The 2025–2027 vesting schedule clusters share deliveries (notably Mar 2025 and Q1 settlements), creating episodic supply but also reinforcing retention; remaining options are minimal (2,652) with 2026 expiry .
  • Execution track record: Finance leadership through capital markets (2021 convert; 2022 facility), cost controls, tax planning, and IR strategy contributed to 2024 equity re‑rating and strong TSR; continued delivery on FCF and installations/signings will be key to PSU outcomes and sustained pay-for-performance alignment .